Literature DB >> 10674620

Decreased surgical risks of pancreas transplantation in the modern era.

A Humar1, R Kandaswamy, D Granger, R W Gruessner, A C Gruessner, D E Sutherland.   

Abstract

OBJECTIVE: To document the decreased incidence of surgical complications after pancreas transplantation in recent times. SUMMARY BACKGROUND DATA: Compared with other abdominal transplants, pancreas transplants have historically had the highest incidence of surgical complications. However, over the past few years, the authors have noted a significant decrease in the incidence of surgical complications.
METHODS: The authors studied the incidence of early (<3 months after transplant) surgical complications (e.g., relaparotomy, thrombosis, infections, leaks) after 580 pancreas transplants performed during a 12-year period. Patients were analyzed and compared in two time groups: era 1 (June 1, 1985, to April 30, 1994, n = 367) and era 2 (May 1, 1994, to June 30, 1997, n = 213).
RESULTS: Overall, surgical complications were significantly reduced in era 2 compared with era 1. The relaparotomy rate decreased from 32.4% in era 1 to 18.8% in era 2. Significant risk factors for early relaparotomy were donor age older than 40 years and recipient obesity. Recipients with relaparotomy had significantly lower graft survival rates than those without relaparotomy, but patient survival rates were not significantly different. A major factor contributing to the lower relaparotomy rate in era 2 was a significant decrease in the incidence of graft thrombosis; the authors believe this lower incidence is due to the routine use of postoperative low-dose intravenous heparin and acetylsalicylic acid. The incidence of bleeding requiring relaparotomy did not differ between the two eras. Older donor age was the most significant risk factor for graft thrombosis. The incidence of intraabdominal infections significantly decreased between the two eras; this decrease may be due to improved prophylaxis regimens in the first postoperative week.
CONCLUSIONS: Although a retrospective study has its limits, the results of this study, the largest single-center experience to date, show a significant decrease in the surgical risk associated with pancreas transplants. Reasons for this decrease are identification of donor and recipient risk factors, better prophylaxis regimens, refinements in surgical technique, and improved immunosuppressive regimens. These improved results suggest that more widespread application of pancreas transplantation is warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674620      PMCID: PMC1420996          DOI: 10.1097/00000658-200002000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Pancreas transplant results in the United Network for Organ Sharing (UNOS) United States of America (USA) Registry compared with non-USA data in the International Registry.

Authors:  A Gruessner; D E Sutherland
Journal:  Clin Transpl       Date:  1994

2.  Duodenal complications in bladder-drained pancreas transplantation.

Authors:  N S Hakim; A C Gruessner; B E Papalois; C Troppmann; D L Dunn; D E Sutherland; R W Gruessner
Journal:  Surgery       Date:  1997-06       Impact factor: 3.982

3.  Should obese patients lose weight before receiving a kidney transplant?

Authors:  C S Modlin; S M Flechner; M Goormastic; D A Goldfarb; D Papajcik; B Mastroianni; A C Novick
Journal:  Transplantation       Date:  1997-08-27       Impact factor: 4.939

4.  Vascular reconstruction in 105 consecutive pancreas transplants.

Authors:  J S Bynon; R J Stratta; R J Taylor; J A Lowell; M Cattral
Journal:  Transplant Proc       Date:  1993-12       Impact factor: 1.066

5.  The surgical risk of pancreas transplantation in the cyclosporine era: an overview.

Authors:  R W Gruessner; D E Sutherland; C Troppmann; E Benedetti; N Hakim; D L Dunn; A C Gruessner
Journal:  J Am Coll Surg       Date:  1997-08       Impact factor: 6.113

6.  Use of FK 506 in pancreas transplantation.

Authors:  R W Gruessner; D E Sutherland; M B Drangstveit; C Troppmann; A C Gruessner
Journal:  Transpl Int       Date:  1996       Impact factor: 3.782

7.  Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.

Authors:  E Benedetti; A C Gruessner; C Troppmann; B E Papalois; D E Sutherland; D L Dunn; R W Gruessner
Journal:  J Am Coll Surg       Date:  1996-10       Impact factor: 6.113

8.  Incidence, management and significance of surgical complications after pancreatic transplantation.

Authors:  V Douzdjian; M M Abecassis; J L Cooper; J L Smith; R J Corry
Journal:  Surg Gynecol Obstet       Date:  1993-11

9.  A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.

Authors:  R W Gruessner; G W Burke; R Stratta; H Sollinger; E Benedetti; C Marsh; P Stock; J P Boudreaux; M Martin; M B Drangstveit; D E Sutherland; A Gruessner
Journal:  Transplantation       Date:  1996-01-27       Impact factor: 4.939

10.  Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis.

Authors:  C Troppmann; A C Gruessner; E Benedetti; B E Papalois; D L Dunn; J S Najarian; D E Sutherland; R W Gruessner
Journal:  J Am Coll Surg       Date:  1996-04       Impact factor: 6.113

View more
  30 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  A mathematical model for shortening waiting time in pancreas-kidney transplantation.

Authors:  Eleazar Chaib; Marcelo Augusto F Ribeiro; Vinicius Rocha Santos; Roberto Ferreira Meirelles; Luiz Augusto Carneiro D'Albuquerque; Eduardo Massad
Journal:  World J Gastrointest Surg       Date:  2011-08-27

3.  [Intensive care treatment following transplant surgery].

Authors:  S Kohler; A Pascher; P Neuhaus
Journal:  Chirurg       Date:  2006-08       Impact factor: 0.955

4.  Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up.

Authors:  P A Gerber; V Pavlicek; N Demartines; R Zuellig; T Pfammatter; R Wüthrich; M Weber; G A Spinas; R Lehmann
Journal:  Diabetologia       Date:  2007-11-01       Impact factor: 10.122

Review 5.  Iatrogenic-related transplant injuries: the role of the interventional radiologist.

Authors:  Alexander Copelan; Daniel George; Baljendra Kapoor; Hahn Vu Nghiem; Jonathan M Lorenz; Brian Erly; Weiping Wang
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 6.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

Review 7.  Exocrine drainage in vascularized pancreas transplantation in the new millennium.

Authors:  Hany El-Hennawy; Robert J Stratta; Fowler Smith
Journal:  World J Transplant       Date:  2016-06-24

8.  Early and late presentations of graft arterial pseudoaneurysm following pancreatic transplantation.

Authors:  Nir Lubezky; Yaacov Goykhman; Richard Nakache; Ada Kessler; Roni Baruch; Paulina Katz; Itzhak Kori; Joseph M Klausner; Menahem Ben-Haim
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

9.  Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets.

Authors:  Adam Frank; Shaoping Deng; Xiaolun Huang; Ergun Velidedeoglu; Yong-Suk Bae; Chengyang Liu; Peter Abt; Robert Stephenson; Muhammad Mohiuddin; Thav Thambipillai; Eileen Markmann; Maral Palanjian; Marty Sellers; Ali Naji; Clyde F Barker; James F Markmann
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

Review 10.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.